OGENOragenics, Inc.
0.5250USD-0.98%Mkt Cap: 2.37M $P/E: 0.543d ago
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is O…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.37M $
Enterprise Value-1.50M $
Revenue (TTM)—
Gross Profit-3.42M $
Net Income (TTM)-9.84M $
Revenue/Share—
Last Price0.5250 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6840235005
Valuation
P/E (Trailing)0.54
P/E (Forward)-0.05
PEG-8.96
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.37
EPS (TTM)0.98
EPS (Forward)-10.80
52W Range
0.48015% of range1.450
52W High1.450 USD
52W Low0.4801 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-118.85%
ROA-97.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.25M $
CapEx (TTM)—
FCF Margin—
FCF Yield-281.99%
Net Debt-3.86M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio3.02
Quick Ratio2.12
Book Value/Sh1.413 USD
Cash/Share0.8560 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 22, 2018
Splits
Last Split1:30
Split DateJun 3, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.51M
Float4.42M
Insiders1.93%
Institutions3.06%
Short Interest
Short Ratio28.9d
Short % Float17.33%
Short % Out.17.31%
Shares Short781.09K
Short (prev mo.)775.02K
Technical
SMA 500.5572 (-5.8%)
SMA 2000.7194 (-27.0%)
Beta1.24
S&P 52W Chg19.18%
Avg Vol (30d)26.82K
Avg Vol (10d)41.08K
Technical Indicators
RSI (14)43.0
MACD-0.0057
MACD Signal-0.0076
MACD Hist.+0.0019
BB Upper0.5657 USD
BB Middle0.5250 USD
BB Lower0.4843 USD
BB Width15.50%
ATR (14)0.0280 USD
Vol Ratio (20d)1.93x